What is Haemophilus Influenza Type B (Hib)?

What is Haemophilus Influenza Type B (Hib)?

IMPORTANT NOTE: Corvelva invites you to get in-depth information by reading all the sections and links, as well as the manufacturer's product leaflets and technical data sheets, and to speak with one or more trusted professionals before deciding to vaccinate yourself or your child. This information is for informational purposes only and is not intended as medical advice.

Haemophilus influenzae (H. influenzae) is a small gram-negative coccobacillus(1) present only in humans(2) and can be encapsulated (typeable) or unencapsulated (non-typeable). Current vaccines against H. influenzae affect only H. influenzae type b, which was thought to be the cause of 95% of all H. influenzae infections in the pre-vaccine era.(3)

The H. influenzae type b (Hib) is transmitted by direct contact with respiratory secretions and enters the body through the upper respiratory tract. 

The diagnosis of H. influenzae, including H. influenzae type b is done through laboratory analysis of bodily fluids such as blood and spinal fluid.(4)

While invasive disease caused by H. influenzae type b (Hib) has decreased, invasive disease caused by non-b, nontypable H. influenzae has increased.(5-6-7-8-9-10-11-12-13-14) Non-b type H. influenzae infections, such as H. influenzae type a, can cause invasive disease with complications similar to those of Hib(15) and nontypable invasive H. influenzae disease, although it is most commonly associated with infections such as conjunctivitis, otitis media, sinusitis, and pneumonia, still has the potential to cause severe invasive H. influenzae disease.(16) Hib vaccines only target H. influenzae type b offer no protection against any other type of H. influenzae infection.(17)


References:

  1. CDC Haemophilus influenzae type b – Haemophilus influenzae Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). 13th ed. 2015.
  2. CDC Haemophilus influenzae type b – Epidemiology Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). 13th ed. 2015.
  3. CDC Haemophilus influenzae type b – Haemophilus influenzae Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). 13th ed. 2015.
  4. CDC Haemophilus influenzae Disease (including Hib) Diagnosis, Treatment, and Complications. Feb. 13, 2018
  5. Bender JM, Cox CM, Mottice S, et al. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin Infect Dis. 2010 Apr 1;50(7):e41-6
  6. Wagoner-Fountain LA, Hendley JO, Cody EJ et al. The emergence of Haemophilus influenzae types e and f as significant pathogens. Clin Infect Dis. 1995 Nov;21(5):1322-4.
  7. Rubach MP, Bender JM, Mottice S et al. Increasing Incidence of Invasive Haemophilus influenzae Disease in Adults, Utah, USA Emerg Infect Dis. 2011 Sep; 17 (9): 1645–1650.
  8. McConnell A, Tan B, Scheifele D, et al. Invasive infections caused by Haemophilus influenzae serotypes in twelve Canadian IMPACT centres, 1996-2001. Pediatric Infect Dis J. 2007 Nov;26(11):1025-31.
  9. Urwin G, Krohn JA, Deaver-Robinson K, et al. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiological characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. Clin Infect Dis. 1996 Jun;22(6):1069-76.
  10. Ulanova M, Tsang RSW Haemophilus influenzae serotype a as a cause of serious invasive infections. Lancet Infect Dis. 2014 Jan;14(1):70-82
  11. Bruce MG, Deeks SL, Zulz T, et al. Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005. Emerg Infect Dis. 2008 Jan;14(1):48-55.
  12. Adam HJ, Richardson SE, Jamieson FB et al. Changing epidemiology of invasive diseases Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccines. 2010 May 28;28(24):4073-8
  13. Langere JD, de Jonge MI Invasive Disease Caused by Nontypeable Haemophilus influenzae Emerg Infect Dis. 2015 Oct; 21 (10): 1711–1718.
  14. Cerquetti M, Giufrè M Why we need a vaccine for non-typeable Haemophilus influenzae. Hum Vaccine Immunother. 2016 Sep; 12 (9): 2357–2361.
  15. 30 Rathore MH Pediatric Haemophilus influenzae Infection - Pathophysiology Medscape Apr. 4, 2016
  16. 31 Murphy TF, Faden H, Bakaletz LO, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatric Infect Dis J. 2009 Jan;28(1):43-8
  17. 32 CDC Haemophilus influenzae Disease (including Hib) – Prevention. Feb. 13, 2018
Corvelva

Publish the Menu module to "offcanvas" position. Here you can publish other modules as well.
Learn more.